ISR Immune System Regulation Holding AB (ISR) is an innovation driven Research Company within the area of immunotherapy, based at the Karolinska Hospital in Stockholm, Sweden. The Company has a focus on preclinical and clinical research with the objective to develop novel drugs for curative treatments of viral infections.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company